COVID-19 is a pandemic disease caused by 2019 Novel Coronavirus or SARS-CoV-2. As this disease is highly contagious and rapidly spreading, so all countries have to increase their level of preparedness, alert, and response to identify, manage, and care for new cases of COVID-19; laboratory testing is an integral part of this strategy. Accurate results by laboratory diagnosis are beneficial for public health.
References
[1]
World Health Organization (2020) Global Name of COVID-19. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/events-as-they-happen
[2]
World Health Organization (2020, April 23) Coronavirus Disease 2019 (COVID-19) Situation Report—94. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/situation-reports
[3]
Singhal, T. (2020) A Review of Coronavirus Disease-2019 (COVID-19). The Indian Journal of Pediatrics, 87, 281-286. https://doi.org/10.1007/s12098-020-03263-6
[4]
Yang, P. and Wang, X. (2020) COVID-19: A New Challenge for Human Beings. Cellular & Molecular Immunology, 17, 555-557. https://doi.org/10.1038/s41423-020-0407-x
[5]
Hassan, S., Sheikh, F.N., Jamal, S., Ezeh, J.K. and Akhtar, A. (2020) Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus, 12, Article ID: e7355. https://doi.org/10.7759/cureus.7355
[6]
Li, X., Geng, M., Peng, Y., Meng, L. and Lu, S. (2020) Molecular Immune Pathogenesis and Diagnosis of COVID-19. Journal of Pharmaceutical Analysis, 10, 102-108. https://doi.org/10.1016/j.jpha.2020.03.001
[7]
Sardar, R., Satish, D., Birla, S. and Gupta, D. (2020) Comparative Analyses of SAR-CoV2 Genomes from Different Geographical Locations and Other Coronavirus Family Genomes Reveals Unique Features Potentially Consequential to Host-Virus Interaction and Pathogenesis. Heliyon, 6, Article ID: E04658. https://doi.org/10.1016/j.heliyon.2020.e04658
[8]
Kakodkar, P., Kaka, N. and Baig, M. (2020) A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19). Cureus, 12, Article No. e7560. https://doi.org/10.7759/cureus.7560
[9]
Liu, J., Liu, Y., Xiang, P., Xiong, H., Li, C., Zhang, M., et al. (2020) Neutrophil to Lymphocyte Ratio Predicts Severe Illness Patients with 2019 Novel Coronavirus in the Early Stage. Journal of Translational Medicine, 18, Article No. 206. https://doi.org/10.1186/s12967-020-02374-0
[10]
Terpos, E., Ntanasis-Stathopoulos, I., Elalamy, I., Kastritis, E., Sergentanis, T.N., Politou, M., et al. (2020) Hematological Findings and Complications of COVID-19. American Journal of Hematology, 95, 834-847. https://doi.org/10.1002/ajh.25829
[11]
IFCC (International Federation of Clinical Chemistry and Laboratory Medicine) (2020) IFCC Information Guide on COVID-19. https://www.ifcc.org/ifcc-news/2020-03-26-ifcc-information-guide-on-covid-19/
[12]
Choudhary, M.L., Vipat, V., Jadhav, S., Basu, A., Cherian, S., Abraham, P., et al. (2020) Development of In Vitro Transcribed RNA as Positive Control for Laboratory Diagnosis of SARS-CoV-2 in India. Indian Journal of Medical Research, 151, 251-254.
[13]
Gupta, N., Bhatnagar, T., Rade, K., Murhekar, M., Gangakhedkar, R.R. and Nagar, A. (2020) Strategic Planning to Augment the Testing Capacity for COVID-19 in India. Indian Journal of Medical Research, 151, 210-215.
[14]
World Health Organization (2020) Laboratory Testing for Coronavirus Disease (COVID-19) in Suspected Human Cases. World Health Organization, Geneva. https://apps.who.int/iris/handle/10665/331329
ICMR (Indian Council of Medical Research) (2020) Protocol for Using “Rapid Antibody Test” in Hot Area—Epidemiological Studies and Surveillance. Indian Council of Medical Research, New Delhi. https://www.icmr.gov.in/pdf/covid/strategy/Rapid_Antibody_test_Protocol.pdf
Euroimmun (2020) Anti-SARS-CoV-2 ELISAs for IgG and IgA. Euroimmun, Lubeck. https://cpcdiagnostics.in/sars-cov-2.php
[19]
World Health Organization (2020) Advice on the Use of Point-of-Care Immunodiagnostic Tests for COVID-19. https://www.who.int/news-room/commentaries/detail/advice-on-the-use-of-point-of-care-immunodiagnostic-tests-for-covid-19
[20]
Soraya, G.V. and Ulhaq, Z.S. (2020) Crucial Laboratory Parameters in Covid-19 Diagnosis and Prognosis: An Updated Meta-Analysis. SSRN Electronic Journal, 1-20. https://doi.org/10.2139/ssrn.3576912
[21]
Velavana, T.P. and Meyera, C.G. (2020) Mild versus Severe COVID-19: Laboratory Markers. International Journal of Infectious Diseases, 95, 304-307. https://doi.org/10.1016/j.ijid.2020.04.061
